The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 (68)Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
德国癌症联盟 (DKTK) 开展了一项多中心前瞻性 1/2 期 (68)Ga-PSMA-11 PET 成像试验，旨在评估其在初诊高危前列腺癌患者中的安全性、诊断准确性以及与组织病理学相比对患者管理的影响。
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07540-4
Giesel, Frederik L; Koerber, Stefan A; Hadaschik, Boris; Kiefer, Selina; Schwarzenboeck, Sarah; Rahbar, Kambiz; Derlin, Thorsten; Grott, Christoph A; Heck, Matthias; Jilg, Cordula; Meyer, Philipp T; Ruf, Juri; Schmidt, Karl; Kotzerke, Joerg; la Fougère, Christian; Reischl, Gerald; Virgolini, Irene; Herrmann, Ken; Burger, Irene A; Lorenzini, Theo; Werner, Martin; Stenzinger, Albrecht; Schwamborn, Kristina; Radtke, Jan Philipp; Hohenfellner, Markus; Debus, Juergen; Weber, Wolfgang A; Haberkorn, Uwe; Kopka, Klaus; Eiber, Matthias
